Question

Anaphylaxis

11 Sep 2025
Answer :
Word Count : 238
Anaphylaxis is a severe, life-threatening systemic hypersensitivity reaction that occurs rapidly after exposure to an allergen. It is classified as a type I hypersensitivity reaction, mediated by immunoglobulin E (IgE). Upon first exposure, the allergen induces sensitization leading to IgE production which binds to receptors on mast cells and basophils. On re-exposure, the allergen cross-links these IgE antibodies, triggering degranulation of mast cells and release of mediators such as histamine, leukotrienes, and prostaglandins. These
______ __________ ____ ____ __________ ___ __________ ________ ___ ___.
________ _______ ___ _________ ___ ________ ________ _______ ________ _____ _______ ___.
____ _______ ______ _______ ________ __________ ____.
________ _____ ___ __________ _____ _____ ________.
____ ________ ___ ___ _____ __________ ________ ____ __________ ______ __________.
_________ ______ _________ _______ ___ ________ _________ _____ _______ __________ __________.
_________ ____ ___ __________ _______ _____ ________ ______ _________ ________ _________ ________.
_______ ___ _____ _________ _______ ___ ____ ____.
__________ ____ _______ _____ __________ __________ _____ ____.
____ ___ __________ ________ ______ ______.
____ _____ ______ _______ _________ ____ __________.
_______ ______ __________ _______ _________ ______ ___ _______ _____.
_____ _____ ___ ________ _____ _______ __________ ______ ________ _________ _________ __________.
________ _______ _________ _____ _________ _________ _______ ____ __________ _____ _________.
________ ____ ________ ___ __________ ____ _______.
________ ___ ________ ______ ______ __________ ____ _____.
___ _________ ______ ________ _______ ______ ___ ___ _______.
________ ______ _____ _________ ____.
_____ ________ __________ _______.
IGNOU ACADEMY
Your IGNOU journey, made easier.
  • Solved Assignments
  • Study Notes
  • Guess Papers
  • Question Papers
Skip in 10
Top
📞
Call Support Instant phone assistance IGNOU MZO 008 2025 - Anaphylaxis | IGNOU Academy
→
🟢
WhatsApp Chat Fast live messaging
→
Email Us Business enquiries & support
→